Showing 1 of 1 PublicationsOff-label use of approved drugsDeVita V. Off-label use of approved drugs. Nature Reviews Clinical Oncology 2009, 6: 181-181. PMID: 19333219, DOI: 10.1038/nrclinonc.2009.41.Peer-Reviewed Original ResearchCitationsMeSH KeywordsAntineoplastic Combined Chemotherapy ProtocolsClinical Trials as TopicColonic NeoplasmsDrug ApprovalDrug LabelingEflornithineGovernment RegulationHumansSulindacUnited StatesUnited States Food and Drug AdministrationDownload Full List
Off-label use of approved drugsDeVita V. Off-label use of approved drugs. Nature Reviews Clinical Oncology 2009, 6: 181-181. PMID: 19333219, DOI: 10.1038/nrclinonc.2009.41.Peer-Reviewed Original ResearchCitationsMeSH KeywordsAntineoplastic Combined Chemotherapy ProtocolsClinical Trials as TopicColonic NeoplasmsDrug ApprovalDrug LabelingEflornithineGovernment RegulationHumansSulindacUnited StatesUnited States Food and Drug Administration